Fecal transplantation for recurrent clostridium difficile infection in older adults: A review

Journal of the American Geriatrics Society

Volumn 61, Issue 8, 2013, Pages 1394-1398

  Burke, Kristin E ^a   Lamont, John T ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

fecal microflora; fecal transplantation; recurrent C. difficile infection

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; BIODIVERSITY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DONOR SELECTION; FECAL TRANSPLANTATION; FECES; FECES MICROFLORA; FOLLOW UP; GASTROENTEROLOGICAL PROCEDURE; HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REMISSION; REVIEW;

FECAL MICROFLORA; FECAL TRANSPLANTATION; RECURRENT C. DIFFICILE INFECTION;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, NECROTIZING; FECES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; METAGENOME; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TRANSPLANTS; TREATMENT FAILURE; VIRULENCE;

EID: 84882283827     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12378     Document Type: Review

References (30)

1. Kelly CP, LaMont JT,. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-1940.
2. Jarvis WR, Schlosser J, Jarvis AA, et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009; 37: 263-270.
3. Johnson S,. Recurrent Clostridium difficile infection: Causality and therapeutic approaches. Int J Antimicrob Agents 2009; 33 (Suppl 1): S33-S36.
4. Pepin J, Routhier S, Gagnon S, et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006; 42: 758-764.
5. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271: 1913-1918.
6. Ghantoji SS, Sail K, Lairson DR, et al. Economic healthcare costs of Clostridium difficile infection: A systematic review. J Hosp Infect 2010; 74: 309-318.
7. Hu MY, Katchar K, Kyne L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009; 136: 1206-1214.
8. Simor AE,. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: A review. J Am Geriatr Soc 2010; 58: 1556-1564.
9. Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990; 336: 97-100.
10. Quinn LK, Chen Y, Herwaldt LA,. Infection control policies and practices for Iowa long-term care facility residents with Clostridium difficile infection. Infect Control Hosp Epidemiol 2007; 28: 1228-1232.
11. Edlund C, Nord CE,. Effect of quinolones on intestinal ecology. Drugs 1999; 58 (Suppl 2): 65-70.
12. Johnson S,. Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes. J Infect 2009; 58: 403-410.
13. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41: 1254-1260.
14. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342: 390-397.
15. Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357: 189-193.
16. Johnson S, Schriever C, Galang M, et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007; 44: 846-848.
17. Johnson S, Gerding DN,. Fidaxomicin 'chaser' regimen following vancomycin for patients with multiple C. difficile recurrences. Clin Infect Dis 2012; 56: 309-310.
18. Aas J, Gessert CE, Bakken JS,. Recurrent Clostridium difficile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-585.
19. Gustafsson A, Berstad A, Lund-Tonnesen S, et al. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 1999; 34: 580-586.
20. Kelly CR, de Leon L, Jasutkar N,. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: Methodology and results. J Clin Gastroenterol 2012; 46: 145-149.
21. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-360.
22. Mattila E, Uusitalo-Seppala R, Wuorela M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-496.
23. Persky SE, Brandt LJ,. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000; 95: 3283-3285.
24. Rohlke F, Surawicz CM, Stollman N,. Fecal flora reconstitution for recurrent Clostridium difficile infection: Results and methodology. J Clin Gastroenterol 2010; 44: 567-570.
25. Schwan A, Sjolin S, Trottestam U, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211-215.
26. Tvede M, Rask-Madsen J,. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156-1160.
27. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415.
28. Khoruts A, Sadowsky MJ,. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 2011; 4: 4-7.
29. Silverman MS, Davis I, Pillai DR,. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 2010; 8: 471-473.
30. Yoon SS, Brandt LJ,. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: A case series of 12 patients. J Clin Gastroenterol 2010; 44: 562-566.